Evaluation of the Leptocheck-WB IgM rapid test for acute leptospirosis among acute undifferentiated fever patients in western Uganda: very low sensitivity against locally circulating Leptospira serogroups
A study in western Uganda found that the Leptocheck-WB IgM rapid test has near-zero sensitivity (1.1–2.2%) for detecting acute leptospirosis caused by locally circulating serogroups, rendering it unsuitable for screening or surveillance in this setting despite its perfect specificity.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Fever is a universal signal that something is wrong inside the body, but in many parts of the world, figuring out exactly what is causing that fever is a difficult puzzle. One of the most common culprits in tropical regions is a bacterial infection called leptospirosis. This disease spreads when people come into contact with water or soil contaminated by the urine of infected animals, such as rats or livestock. The bacteria can enter the body through cuts in the skin or mucous membranes, leading to symptoms that range from a mild flu-like illness to severe, life-threatening complications. Because the early signs of leptospirosis look so much like malaria or other common fevers, doctors often treat the wrong disease or miss the infection entirely until it is too late. To stop this, medical teams need a way to spot the infection quickly at the bedside, using a simple test that does not require a complex laboratory.
In western Uganda, a team of researchers set out to see if one such quick test, known as the Leptocheck-WB, could solve this problem. This test is designed to be used in clinics where advanced equipment is unavailable. It works by looking for specific proteins in a patient's blood called antibodies. When the body fights off leptospirosis, it creates these antibodies, and the test is supposed to light up if they are present. The researchers gathered 330 patients who had come to local hospitals with unexplained fevers. They took blood and urine samples from everyone and ran them through the rapid test. To be absolutely sure who actually had the disease, they also used two highly accurate, gold-standard methods: a molecular test that detects the bacteria's genetic material directly, and a specialized laboratory test that measures how well the patient's blood reacts to different strains of the bacteria.
The results were stark and surprising. Out of the 330 patients, the gold-standard methods confirmed that 89 of them had acute leptospirosis. Yet, when the researchers looked at the results from the rapid test, it had failed to identify almost all of them. In the first group of tests, the rapid kit found only one of the 89 confirmed cases. In a second group of tests using a different batch of the same kit, it found only two. This means the test missed more than 97 percent of the people who were actually sick. While the test was perfect at saying "no" when a person was healthy, its inability to say "yes" when a person was sick made it useless for finding the disease in this population.
The researchers dug deeper to understand why the test failed so badly. They considered whether the timing of the test was the issue, perhaps because patients arrived too early for their bodies to have made enough antibodies. However, the data showed that the test also failed to detect patients who had already developed strong, high-level antibodies. It even missed people whose blood reacted strongly to the bacteria in the gold-standard lab test. The key to the mystery lay in the specific types of bacteria circulating in Uganda. The rapid test was designed to recognize a broad range of bacteria, but it seemed to work best against a specific type common in Asia and Europe. In western Uganda, the bacteria causing the illness belonged to different groups, specifically types known as Bataviae and Tarassovi. The test simply did not recognize these local strains, even when the patients' immune systems were clearly fighting them.
This finding carries a heavy weight for doctors and health workers in the region. It means that relying on this rapid test to rule out leptospirosis could be dangerous, as a negative result would give a false sense of security. The test is not broken in the sense that it does not work at all; it works perfectly for the specific bacteria it was built to see, but those bacteria are not the ones causing the fever in this part of Africa. The study concludes that for a rapid test to be useful here, it must be designed to recognize the local strains of the bacteria. Until such a tool is developed and proven, doctors in western Uganda cannot use this quick test to guide their treatment, and they must rely on clinical judgment and more complex laboratory methods to save lives.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.